FOS and hepatocellular carcinoma: It was found that HCC patients with high expressions of GTF2H2 (log-rank P = 0.011) and DACH1 (log-rank P = 0.13) had a poorer OS probability, while those with high expressions of FOSB (log-rank P = 0.0024), ASCL1 (log-rank P = 0.0029), EBF1 (log-rank P = 0.048), and FOS (log-rank P = 0.23) had a better probability of OS.